Streptavidin-coated magnetic beads for DNA strand separation implicate a multitude of problems during cell-SELEX.

Using whole living cells as a target for SELEX (systematic evolution of ligands by exponential enrichment) experiments represents a promising method to generate cell receptor-specific aptamers. These aptamers have a huge potential in diagnostics, therapeutics, imaging, regenerative medicine, and target validation. During the SELEX for selecting DNA aptamers, one important step is the separation of 2 DNA strands to yield one of the 2 strands as single-stranded DNA aptamer. This is being done routinely by biotin labeling of the complementary DNA strand to the desired aptamer and then separating the DNA strand by using streptavidin-coated magnetic beads. After immobilization of the double-stranded DNA on these magnetic beads and alkaline denaturation, the non-biotinylated strand is being eluted and the biotinylated strand is retarded. Using Western blot analysis, we demonstrated the detachment of covalent-bonded streptavidin from the bead surface after alkaline treatment. The eluates were also contaminated with undesired biotinylated strands. Furthermore, a streptavidin-induced aggregation of target cells was demonstrated by flow cytometry and microscopic methods. Cell-specific enrichment of aptamers was not possible due to clustering and patching effects triggered by streptavidin. Therefore, the use of streptavidin-coated magnetic beads for DNA strand separation should be examined thoroughly, especially for cell-SELEX applications.

[1]  H A Erlich,et al.  Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[2]  H. Ochman,et al.  Production of single-stranded DNA templates by exonuclease digestion following the polymerase chain reaction. , 1989, Nucleic acids research.

[3]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[4]  S. Bodary,et al.  The integrin beta 1 subunit associates with the vitronectin receptor alpha v subunit to form a novel vitronectin receptor in a human embryonic kidney cell line. , 1990, The Journal of biological chemistry.

[5]  N M Green,et al.  Avidin and streptavidin. , 1990, Methods in enzymology.

[6]  N. Kieffer,et al.  Platelet membrane glycoproteins: functions in cellular interactions. , 1990, Annual review of cell biology.

[7]  L. Gold,et al.  Autogenous translational operator recognized by bacteriophage T4 DNA polymerase. , 1990, Journal of molecular biology.

[8]  Green Nm,et al.  Avidin and streptavidin. , 1990 .

[9]  M. Espelund,et al.  A simple method for generating single-stranded DNA probes labeled to high activities. , 1990, Nucleic acids research.

[10]  M. Wilchek,et al.  Streptavidin contains an RYD sequence which mimics the RGD receptor domain of fibronectin. , 1990, Biochemical and biophysical research communications.

[11]  M. Wilchek,et al.  Cell-adhesive properties of streptavidin are mediated by the exposure of an RGD-like RYD site. , 1992, European journal of cell biology.

[12]  M. Wilchek,et al.  Cell adhesion to streptavidin via RGD-dependent integrins. , 1993, European journal of cell biology.

[13]  E. Topol,et al.  Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. , 1995, The New England journal of medicine.

[14]  D. Bartel,et al.  PCR product with strands of unequal length. , 1995, Nucleic acids research.

[15]  N. Pagratis.  Rapid preparation of single stranded DNA from PCR products by streptavidin induced electrophoretic mobility shift. , 1996, Nucleic acids research.

[16]  T. Fitzwater,et al.  A SELEX primer. , 1996, Methods in enzymology.

[17]  J. F. Curran,et al.  An allosteric synthetic DNA. , 1999, Nucleic acids research.

[18]  S. Jayasena.  Aptamers: an emerging class of molecules that rival antibodies in diagnostics. , 1999, Clinical chemistry.

[19]  V. Petrenko,et al.  Phages from landscape libraries as substitute antibodies. , 2000, Protein engineering.

[20]  Ying-Fon Chang,et al.  Tenascin-C Aptamers Are Generated Using Tumor Cells and Purified Protein* , 2001, The Journal of Biological Chemistry.

[21]  D. Engelke,et al.  Streptavidin aptamers: affinity tags for the study of RNAs and ribonucleoproteins. , 2001, RNA.

[22]  H. Schluesener,et al.  Systematic Evolution of a DNA Aptamer Binding to Rat Brain Tumor Microvessels , 2001, The Journal of Biological Chemistry.

[23]  A D Ellington,et al.  Toward Automated Nucleic Acid Enzyme Selection , 2001, Biological chemistry.

[24]  D. S. Coffey,et al.  Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. , 2002, Cancer research.

[25]  Henning Ulrich,et al.  In Vitro Selection of RNA Aptamers That Bind to Cell Adhesion Receptors of Trypanosoma cruzi and Inhibit Cell Invasion* , 2002, The Journal of Biological Chemistry.

[26]  Pascale Romby,et al.  High affinity nucleic acid aptamers for streptavidin incorporated into bi-specific capture ligands. , 2002, Nucleic acids research.

[27]  Petra Burgstaller,et al.  Aptamers as tools for target prioritization and lead identification. , 2002, Drug discovery today.

[28]  L. Gold,et al.  A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  P. Richardson,et al.  An improved method for the in vitro evolution of aptamers and applications in protein detection and purification. , 2003, Nucleic acids research.

[30]  Bertrand Tavitian,et al.  Neutralizing Aptamers from Whole-Cell SELEX Inhibit the RET Receptor Tyrosine Kinase , 2005, PLoS biology.

[31]  H. Wendel,et al.  Aptamer‐based capture molecules as a novel coating strategy to promote cell adhesion , 2005, Journal of cellular and molecular medicine.

[32]  R. Stoltenburg,et al.  FluMag-SELEX as an advantageous method for DNA aptamer selection , 2005, Analytical and bioanalytical chemistry.

[33]  M. Blank,et al.  Aptamers as tools for target validation. , 2005, Current opinion in chemical biology.

[34]  B. Sullenger,et al.  Aptamers: an emerging class of therapeutics. , 2005, Annual review of medicine.

[35]  P. White,et al.  High-Affinity Aptamers to Subtype 3a Hepatitis C Virus Polymerase Display Genotypic Specificity , 2006, Antimicrobial Agents and Chemotherapy.

[36]  Yong Wang,et al.  Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras , 2006, Nature Biotechnology.

[37]  Ping Wang,et al.  DNA Aptamers That Bind to PrPC and Not PrpSc Show Sequence and Structure Specificity , 2006, Experimental biology and medicine.

[38]  Yoshikazu Nakamura,et al.  Selection of RNA aptamers against recombinant transforming growth factor-beta type III receptor displayed on cell surface. , 2006, Biochimie.

[39]  杨朝勇.  Aptamers evolved from live cells as effective molecular probes for cancer study , 2006 .

[40]  Andrew D Ellington,et al.  Aptamer:toxin conjugates that specifically target prostate tumor cells. , 2006, Cancer research.

[41]  Ying-Fon Chang,et al.  Tumor targeting by an aptamer. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[42]  Gerhard Ziemer,et al.  A New Technique for the Isolation and Surface Immobilization of Mesenchymal Stem Cells from Whole Bone Marrow Using High‐Specific DNA Aptamers , 2006, Stem cells.

[43]  Andrew D. Ellington,et al.  Aptamer mediated siRNA delivery , 2006, Nucleic acids research.

[44]  Kemin Wang,et al.  Selection of aptamers for molecular recognition and characterization of cancer cells. , 2007, Analytical chemistry.

[45]  C D Claussen,et al.  Aptamer-based isolation and subsequent imaging of mesenchymal stem cells in ischemic myocard by magnetic resonance imaging. , 2007, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[46]  Ariel D. Anbar,et al.  Aptamers Evolved from Cultured Cancer Cells Reveal Molecular Differences of Cancer Cells in Patient Samples , 2007 .

[47]  D. Shangguan,et al.  Aptamer Directly Evolved from Live Cells Recognizes Membrane Bound Immunoglobin Heavy Mu Chain in Burkitt's Lymphoma Cells*S , 2007, Molecular & Cellular Proteomics.

[48]  L. Cerchia,et al.  Nucleic acid-based aptamers as promising therapeutics in neoplastic diseases. , 2007, Methods in molecular biology.

[49]  Joshua E. Smith,et al.  Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells. , 2007, Analytical chemistry.

[50]  Michael Famulok,et al.  Enrichment of cell-targeting and population-specific aptamers by fluorescence-activated cell sorting. , 2008, Angewandte Chemie.